These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2016444)

  • 1. Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation.
    Weiner HL; McCarthy EA; Pritchett EL
    J Am Coll Cardiol; 1991 May; 17(6):1283-7. PubMed ID: 2016444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia.
    Hamer ME; Wilkinson WE; Clair WK; Page RL; McCarthy EA; Pritchett EL
    J Am Coll Cardiol; 1995 Apr; 25(5):984-8. PubMed ID: 7897142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
    Botto GL; Bonini W; Broffoni T; Cappelletti G; Falcone C; Lombardi R; Paulesu A; Pedraglio E; Ferrari G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2114-7. PubMed ID: 7845827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow QRS complex tachycardia presenting as palpitation.
    Singh D; Teo SG; Kireyev D; Poh KK
    Singapore Med J; 2011 Jul; 52(7):468-73; quiz 474. PubMed ID: 21808955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of adenosine in patients hospitalized in a university medical center.
    Knight BP; Zivin A; Souza J; Goyal R; Man KC; Strickberger A; Morady F
    Am J Med; 1998 Oct; 105(4):275-80. PubMed ID: 9809687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
    Antman EM; Beamer AD; Cantillon C; McGowan N; Friedman PL
    J Am Coll Cardiol; 1990 Mar; 15(3):698-707. PubMed ID: 2303641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Detection of Symptomatic Paroxysmal Cardiac Arrhythmias by Trans-Telephonic ECG Monitoring: Impact on Diagnosis and Treatment of Atrial Fibrillation.
    Anczykowski J; Willems S; Hoffmann BA; Meinertz T; Blankenberg S; Patten M
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1032-7. PubMed ID: 27257094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
    Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
    Nabar A; Rodriguez LM; Timmermans C; van Mechelen R; Wellens HJ
    Heart; 2001 Apr; 85(4):424-9. PubMed ID: 11250970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.